CLINICAL TRIALS PROFILE FOR NABILONE

All Clinical Trials for NABILONE

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00272207 ↗	A Trial Assessing the Effect of Nabilone on Pain and Quality of Life in Patients With Fibromyalgia	Completed	Valeant Canada Limited	Phase 2	2006-04-01	The purpose of the study is to determine whether or not the drug Nabilone significantly reduces pain and improves quality of life in patients with fibromyalgia.
NCT00272207 ↗	A Trial Assessing the Effect of Nabilone on Pain and Quality of Life in Patients With Fibromyalgia	Completed	Winnipeg Regional Health Authority	Phase 2	2006-04-01	The purpose of the study is to determine whether or not the drug Nabilone significantly reduces pain and improves quality of life in patients with fibromyalgia.
NCT00381199 ↗	Nabilone Versus Amitriptyline in Improving Quality of Sleep in Patients With Fibromyalgia	Completed	McGill University Health Center	N/A	2006-04-01	Most chronic pain patients with insomnia are currently not well-managed using existing medications. If found to safely improve sleep with chronic pain patients, nabilone could be added to the treatment options available in the management of fibromyalgia and associated symptoms. The principle hypothesis of this study is that nabilone at a dose of 0.5-1mg is as efficacious as amitriptyline at a dose of 10-20mg, in improving sleep quality in patients with fibromyalgia.
NCT00381199 ↗	Nabilone Versus Amitriptyline in Improving Quality of Sleep in Patients With Fibromyalgia	Completed	McGill University Health Centre/Research Institute of the McGill University Health Centre	N/A	2006-04-01	Most chronic pain patients with insomnia are currently not well-managed using existing medications. If found to safely improve sleep with chronic pain patients, nabilone could be added to the treatment options available in the management of fibromyalgia and associated symptoms. The principle hypothesis of this study is that nabilone at a dose of 0.5-1mg is as efficacious as amitriptyline at a dose of 10-20mg, in improving sleep quality in patients with fibromyalgia.
NCT00384410 ↗	Use of the Cannabinoid Nabilone for the Promotion of Sleep in Chronic, Non-Malignant Pain Patients	Unknown status	Bausch Health Americas, Inc.	Phase 2	2005-12-01	Sleep disturbance is perhaps one of the most prevalent complaints of patients with long-standing painful conditions. Nabilone is a medication that is approved by Health Canada as an anti-emetic (prevent vomiting) for patients undergoing chemotherapy. Nabilone, due to its sleep promoting properties, is sometimes prescribed by physicians to pain patients to help improve their sleep. However, there is no direct research evidence to either support or refute this practice. This study will investigate if nabilone is effective in improving sleep in insomnia and pain patients.
NCT00384410 ↗	Use of the Cannabinoid Nabilone for the Promotion of Sleep in Chronic, Non-Malignant Pain Patients	Unknown status	Valeant Pharmaceuticals International, Inc.	Phase 2	2005-12-01	Sleep disturbance is perhaps one of the most prevalent complaints of patients with long-standing painful conditions. Nabilone is a medication that is approved by Health Canada as an anti-emetic (prevent vomiting) for patients undergoing chemotherapy. Nabilone, due to its sleep promoting properties, is sometimes prescribed by physicians to pain patients to help improve their sleep. However, there is no direct research evidence to either support or refute this practice. This study will investigate if nabilone is effective in improving sleep in insomnia and pain patients.
NCT00384410 ↗	Use of the Cannabinoid Nabilone for the Promotion of Sleep in Chronic, Non-Malignant Pain Patients	Unknown status	University Health Network, Toronto	Phase 2	2005-12-01	Sleep disturbance is perhaps one of the most prevalent complaints of patients with long-standing painful conditions. Nabilone is a medication that is approved by Health Canada as an anti-emetic (prevent vomiting) for patients undergoing chemotherapy. Nabilone, due to its sleep promoting properties, is sometimes prescribed by physicians to pain patients to help improve their sleep. However, there is no direct research evidence to either support or refute this practice. This study will investigate if nabilone is effective in improving sleep in insomnia and pain patients.

Clinical Trial Conditions for NABILONE

Condition Name

Condition Name for NABILONE
Intervention	Trials
Neuropathic Pain	3
Healthy	3
Parkinson Disease	3
Fibromyalgia	3

Condition MeSH

Condition MeSH for NABILONE
Intervention	Trials
Neuralgia	5
Marijuana Abuse	5
Parkinson Disease	3
Alzheimer Disease	3

Clinical Trial Locations for NABILONE

Trials by Country

Trials by Country for NABILONE
Location	Trials
Canada	17
United States	7
Austria	2
Mexico	1
Denmark	1

Trials by US State

Trials by US State for NABILONE
Location	Trials
New York	4
Texas	1
Maryland	1
Massachusetts	1

Clinical Trial Progress for NABILONE

Clinical Trial Phase

Clinical Trial Phase for NABILONE
Clinical Trial Phase	Trials
Phase 4	3
Phase 3	7
Phase 2/Phase 3	4

Clinical Trial Status

Clinical Trial Status for NABILONE
Clinical Trial Phase	Trials
Completed	15
Not yet recruiting	10
Unknown status	5

Clinical Trial Sponsors for NABILONE

Sponsor Name

Sponsor Name for NABILONE
Sponsor	Trials
University of Manitoba	5
New York State Psychiatric Institute	5
Valeant Canada Limited	3

Sponsor Type

Sponsor Type for NABILONE
Sponsor	Trials
Other	45
Industry	10
NIH	4